MiMedx Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MiMedx Group generated cash of $26,775,000, which is more than the previous year. Cash used in financing activities reached the amount of -$8,570,000 last year. Net change in cash is therefore $16,050,000.
Cash Flow
| 2014 | 16.80M | -12.15M | -2.14M |
|---|---|---|---|
| 2015 | 18.80M | -678K | -36.22M |
| 2016 | 25.82M | -11.74M | -8.18M |
| 2017 | 62.93M | -5.39M | -60.38M |
| 2018 | 35.79M | -9.22M | -8.93M |
| 2019 | -39.41M | 504K | 62.85M |
| 2020 | -30.26M | -4.55M | 61.56M |
| 2021 | -1.98M | -3.39M | -3.35M |
| 2022 | -17.89M | -2.66M | -580K |
| 2023 | 26.77M | -2.15M | -8.57M |
MDXG Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 65.95M | 87.08M | 95.81M | 69.06M | 45.11M | 27.47M | 30.32M | 28.48M | 46.58M | 44.07M |
Operating activities | ||||||||||
Net income | 67.43M | -30.19M | -10.28M | -49.28M | -25.58M | -29.97M | 64.72M | 11.97M | 29.44M | 6.22M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.42M | 4.04M | 5.18M | 6.85M | 7.58M | 6.91M | 5.76M | 5.46M | 2.73M | 2.12M |
Stock-based compensation expense | 16.95M | 11.32M | 14.15M | 15.35M | 12.06M | 0 | 21.19M | 17.81M | 16.89M | 11.45M |
| Deferred income tax benefit | 16.95M | 11.32M | 14.15M | 15.35M | 12.06M | 0 | 21.19M | 17.81M | 16.89M | 11.45M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -12.23M | -5.55M | -4.93M | -3.09M | -10.93M | 16.45M | -479K | -11.39M | -27.08M | -10.57M |
Inventories | -7.83M | -1.79M | -1.02M | -1.25M | 6.88M | -6.51M | 2.74M | -2.83M | -2.32M | -1.25M |
Accounts payable | 783K | 1.05M | -326K | 177K | -6.17M | 6.58M | -1.32M | -3.66M | 3.13M | 1.28M |
Cash generated by operating activities | 26.77M | -17.89M | -1.98M | -30.26M | -39.41M | 35.79M | 62.93M | 25.82M | 18.80M | 16.80M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 842K | 6M | -9M |
Investments In Property Plant And Equipment | -1.98M | -2.68M | -3.47M | -4.55M | -2.21M | -10.02M | -5.39M | -7.11M | -6.67M | -3.15M |
Acquisitions Net | 0 | 24K | 0 | 0 | 0 | 30K | 0 | -7.63M | -6M | 0 |
Cash generated by investing activities | -2.15M | -2.66M | -3.39M | -4.55M | 504K | -9.22M | -5.39M | -11.74M | -678K | -12.15M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 1.43M | 100M | 0 | 3.55M | 0 | 3.49M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -9.51M | -1.19M | -4.75M | -2.33M | -1.47M | -12.48M | -72.34M | -11.54M | -40.27M | -5.61M |
Repayments of term debt | -52K | -41K | -38K | -85.31M | 70.87M | -3K | -29K | -102K | -117K | -117K |
Cash used in financing activities | -8.57M | -580K | -3.35M | 61.56M | 62.85M | -8.93M | -60.38M | -8.18M | -36.22M | -2.14M |
Net Change In Cash | 16.05M | -21.13M | -8.72M | 26.74M | 23.95M | 17.64M | -2.84M | 5.90M | -18.09M | 2.50M |
Cash at end of period | 82M | 65.95M | 87.08M | 95.81M | 69.06M | 45.11M | 27.47M | 34.39M | 28.48M | 46.58M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |